Annual Operating Expenses
$131.19 M
+$5.57 M+4.44%
December 31, 2023
Summary
- As of February 8, 2025, TNYA annual total operating expenses is $131.19 million, with the most recent change of +$5.57 million (+4.44%) on December 31, 2023.
- During the last 3 years, TNYA annual operating expenses has risen by +$92.28 million (+237.15%).
- TNYA annual operating expenses is now at all-time high.
Performance
TNYA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$26.71 M
-$4.11 M-13.34%
September 30, 2024
Summary
- As of February 8, 2025, TNYA quarterly total operating expenses is $26.71 million, with the most recent change of -$4.11 million (-13.34%) on September 30, 2024.
- Over the past year, TNYA quarterly operating expenses has dropped by -$4.21 million (-13.61%).
- TNYA quarterly operating expenses is now -23.91% below its all-time high of $35.10 million, reached on June 30, 2023.
Performance
TNYA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TNYA Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.4% | -13.6% |
3 y3 years | +237.2% | -13.6% |
5 y5 years | +373.4% | -13.6% |
TNYA Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +80.2% | -23.9% | +2.1% |
5 y | 5-year | at high | +373.4% | -23.9% | +201.1% |
alltime | all time | at high | +373.4% | -23.9% | +201.1% |
Tenaya Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $26.71 M(-13.3%) |
Jun 2024 | - | $30.82 M(-8.7%) |
Mar 2024 | - | $33.76 M(+7.4%) |
Dec 2023 | $131.19 M(+4.4%) | $31.45 M(+1.7%) |
Sep 2023 | - | $30.92 M(-11.9%) |
Jun 2023 | - | $35.10 M(+4.1%) |
Mar 2023 | - | $33.72 M(-2.4%) |
Dec 2022 | $125.62 M | $34.55 M(+10.4%) |
Sep 2022 | - | $31.30 M(+9.4%) |
Jun 2022 | - | $28.62 M(-8.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $31.15 M(+19.1%) |
Dec 2021 | $72.81 M(+87.1%) | $26.16 M(+43.0%) |
Sep 2021 | - | $18.30 M(+20.1%) |
Jun 2021 | - | $15.24 M(+16.3%) |
Mar 2021 | - | $13.11 M(+27.0%) |
Dec 2020 | $38.91 M(+40.4%) | - |
Dec 2020 | - | $10.32 M(-1.2%) |
Sep 2020 | - | $10.45 M(+17.8%) |
Jun 2020 | - | $8.87 M(-4.3%) |
Mar 2020 | - | $9.27 M |
Dec 2019 | $27.71 M | - |
FAQ
- What is Tenaya Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual operating expenses year-on-year change?
- What is Tenaya Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly operating expenses year-on-year change?
What is Tenaya Therapeutics annual total operating expenses?
The current annual operating expenses of TNYA is $131.19 M
What is the all time high annual operating expenses for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual total operating expenses is $131.19 M
What is Tenaya Therapeutics annual operating expenses year-on-year change?
Over the past year, TNYA annual total operating expenses has changed by +$5.57 M (+4.44%)
What is Tenaya Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TNYA is $26.71 M
What is the all time high quarterly operating expenses for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly total operating expenses is $35.10 M
What is Tenaya Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TNYA quarterly total operating expenses has changed by -$4.21 M (-13.61%)